# Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

> **NCT00143143** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 300 (—)

## Conditions studied

- Epilepsies, Partial
- Epilepsy, Complex Partial

## Interventions

- **DRUG:** Pregabalin

## Key facts

- **NCT ID:** NCT00143143
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-09
- **Primary completion:** —
- **Final completion:** 2006-02
- **Target enrollment:** 300 (—)
- **Last updated:** 2006-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00143143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00143143, "Pregabalin Open-Label Extension Trial in Patients With Partial Seizures". Retrieved via AI Analytics 2026-08-18 from https://api.ai-analytics.org/clinical/NCT00143143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*